| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 30, 2025 | MEDP Medpace Holdings, Inc. | Davenport Fred B Jr | Director | Sell | 5,972 | $581.88 | $3,474,987.36 | -63.1% | +3.0% | - | |
| Oct 30, 2025 | TWST Twist Bioscience Corp | Leproust Emily M.77 | Chief Executive Officer | Sell | 31,379 | $31.44 | $986,690.69 | -4.1% | +34.8% | - | |
| Oct 30, 2025 | TWST Twist Bioscience Corp | Finn Patrick John73 | President And COO | Sell | 17,606 | $31.44 | $553,608.35 | -6.1% | +34.8% | - | |
| Oct 30, 2025 | TWST Twist Bioscience Corp | Laponis Adam58 | Chief Financial Officer | Sell | 5,517 | $31.44 | $173,478.20 | -4.7% | +34.8% | - | |
| Oct 29, 2025 | WGS Genedx Holdings Corp. | Feeley Kevin46 | Chief Financial Officer | Sell | 388 | $136.54 | $52,977.52 | -9.4% | -27.1% | - | |
| Oct 29, 2025 | WGS Genedx Holdings Corp. | Stueland Katherine | Chief Executive Officer | Sell | 2,158 | $136.54 | $294,654.16 | -23.9% | -27.1% | - | |
| Oct 29, 2025 | IQV Iqvia Holdings Inc. | Sherbet Eric57 | See Remarks | Sell | 4,000 | $219.70 | $878,800.00 | -12.9% | +10.7% | - | |
| Oct 29, 2025 | IQV Iqvia Holdings Inc. | Bousbib Ari64 | See Remarks | Sell | 56,557 | $220.33 | $12,461,119.18 | -1.1% | +10.7% | - | |
| Oct 29, 2025 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 5,063 | $191.15 | $967,777.76 | -0.8% | +24.7% | - | |
| Oct 29, 2025 | MEDP Medpace Holdings, Inc. | Geiger Jesse J60 | President | Sell | 23,028 | $602.00 | $13,862,915.20 | -24.0% | +3.0% | - | |
| Oct 28, 2025 | NTRA Natera, Inc. | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 2,206 | $191.86 | $423,233.95 | -0.9% | +27.3% | - | |
| Oct 28, 2025 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 1,993 | $191.87 | $382,389.63 | -0.5% | +27.3% | - | |
| Oct 28, 2025 | NTRA Natera, Inc. | Fesko John | President, Chief Bus. Officer | Sell | 1,709 | $191.86 | $327,881.69 | -0.6% | +27.3% | - | |
| Oct 28, 2025 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 6,015 | $191.80 | $1,153,656.33 | -1.9% | +27.3% | - | |
| Oct 28, 2025 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 479 | $191.98 | $91,958.53 | -0.1% | +27.3% | - | |
| Oct 27, 2025 | MEDP Medpace Holdings, Inc. | Ewald Stephen P59 | General Counsel &Corp. Secy. | Sell | 15,230 | $598.85 | $9,120,485.50 | -53.3% | +0.9% | - | |
| Oct 27, 2025 | MEDP Medpace Holdings, Inc. | Burwig Susan E64 | Exec. VP, Operations | Sell | 2,000 | $605.01 | $1,210,020.00 | -3.0% | +0.9% | - | |
| Oct 27, 2025 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chairman &CEO | Sell | 24,354 | $571.33 | $13,914,103.80 | -1.3% | +11.1% | - | |
| Oct 24, 2025 | TMO Thermo Fisher Scientific Inc. | Pettiti Gianluca63 | Executive Vice President | Sell | 400 | $574.15 | $229,660.00 | -1.9% | +11.7% | - | |
| Oct 24, 2025 | EXAS Exact Sciences Corp | Zanotti Katherine S50 | Director | Sell | 12,000 | $65.00 | $780,000.00 | -16.5% | +58.4% | - | |
| Oct 24, 2025 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 2,170 | $190.30 | $412,951.15 | -1.0% | +26.2% | - | |
| Oct 23, 2025 | TWST Twist Bioscience Corp | Finn Patrick John73 | President And COO | Sell | 2,240 | $30.88 | $69,160.00 | -1.1% | +37.1% | - | |
| Oct 21, 2025 | NTRA Natera, Inc. | Fesko John | President, Chief Bus. Officer | Sell | 339 | $187.95 | $63,715.05 | -0.2% | +25.7% | - | |
| Oct 21, 2025 | NTRA Natera, Inc. | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 292 | $187.95 | $54,881.40 | -0.2% | +25.7% | - | |
| Oct 21, 2025 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 93 | $187.95 | $17,479.35 | - | +25.7% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.